Trial intelligence / Profile preview

Therapeutic benefit of morphine post-conditioning in acute myocardial infarction

2009-017860-17Phase 3Completed

Sponsor
Société Française de Cardiologie
Start
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of morphine in myocardial infarction (MI) (2 arms), sponsored by Société Française de Cardiologie. Primary endpoint: Infarct size on cardiac MRI. Started Dec 2009; status: completed.

02

Drugs

morphine
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on 2009-017860-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-017860-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call